ProCE Banner Activity

Actionable Biomarkers in Lung Cancer: Clinical Applications for Nursing Practice

Slideset Download
Download these slides from an expert-led program on the role of biomarker testing and practical application of recently approved targeted therapies in NSCLC.

Released: September 20, 2022

Expiration: September 19, 2023

Share

Faculty

Beth Sandy

Beth Sandy, MSN, CRNP

Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Elizabeth S. Waxman

Elizabeth S. Waxman, BSN, MSN, ANP-BC

Adult Nurse Practitioner
Thoracic/Head & Neck Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Lilly

Merck Sharp & Dohme Corp.

Novartis Pharmaceuticals Corporation

Regeneron Pharmaceuticals, Inc.

Sanofi Genzyme

Faculty Disclosure

Primary Author

Beth Sandy, MSN, CRNP

Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Beth Sandy, MSN, CRNP, has disclosed that she has received consultant/advisor/speaker fees from Amgen, AstraZeneca, Janssen, Jazz, Merck, and Takeda.

Elizabeth S. Waxman, BSN, MSN, ANP-BC

Adult Nurse Practitioner
Thoracic/Head & Neck Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas

Elizabeth S. Waxman, BSN, MSN, ANP-BC, has no relevant conflicts of interest to report.